🇺🇸 FDA
Patent

US 12102617

Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent

granted A61KA61K31/198A61K31/4164

Quick answer

US patent 12102617 (Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/198, A61K31/4164, A61K31/4166, A61K31/4174